TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Merck Life Science AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,305,238
|
1,251,207
|
906,211 |
Financial expenses |
0
|
1,159
|
29 |
Earnings before taxes |
710,028
|
672,573
|
601,916 |
EBITDA |
670,825
|
669,081
|
601,839 |
Total assets |
1,454,869
|
867,981
|
562,777 |
Current assets |
1,440,851
|
853,998
|
488,995 |
Current liabilities |
97,138
|
125,924
|
65,782 |
Equity capital |
1,346,799
|
731,833
|
491,129 |
- share capital |
10,434
|
9,743
|
10,045 |
Employees (average) |
48
|
46
|
29 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
92.6%
|
84.3%
|
87.3% |
Turnover per employee |
27,192
|
27,200
|
31,249 |
Profit as a percentage of turnover |
54.4%
|
53.8%
|
66.4% |
Return on assets (ROA) |
48.8%
|
77.6%
|
107.0% |
Current ratio |
1483.3%
|
678.2%
|
743.4% |
Return on equity (ROE) |
52.7%
|
91.9%
|
122.6% |
Change turnover |
-34,751
|
372,232
|
178,603 |
Change turnover % |
-3%
|
42%
|
25% |
Chg. No. of employees |
2
|
17
|
0 |
Chg. No. of employees % |
4%
|
59%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.